The US Food and Drug Administration approved on Tuesday the use of the booster shots of Pfizer-BioNTech for children aged 5-11, International Business Times (IBT) reported.
The latest decision will give everyone in the country their third shot.
Children under the age of five are not yet allowed to get COVID-19 vaccine in the country.
Last month, leading drug-makers Pfizer and BioNTech submitted a request to get the approval of the Food and Drug Authority (FDA) for booster shots for children between 5 and 11.
The request from the drug-makers came after a new study showed that the booster shots could give the children strong immune response against COVID-19.
The booster dose will be given to children six months after receiving the essential doses.
It is worthy to mention that the US health authorities approved a second COVID-19 booster dose for two vaccines: Pfizer and Moderna, for people aged 50 and older last March.
The essential motive for issuing such a decision was raising the immune response of aged people against the Omicron variant risks.
The U.S. Food and Drug Administration agency said the fourth dose will be dedicated to those who were vaccinated by the Pfizer Inc (PFE.N)/BioNTech and Moderna vaccines are to be administered at least four months after the latest dose.
The FDA also authorized the fourth shot for younger people who aged 12 and older for the Pfizer/BioNTech shot and 18 and older for Moderna’s.